Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Defyuv Oral Suspension

Prescription Icon
Prescription Required

Marketer

Yuventis Lifesciences

Salt Composition

Deflazacort (6mg/5ml)

Overview Defyuv Oral Suspension

Pedialyte-C, a corticosteroid-based oral suspension, effectively manages various pediatric conditions due to its anti-inflammatory and immunosuppressive actions. It's a cornerstone treatment for Duchenne muscular dystrophy in infants and children. Administer Pedialyte-C orally to your child, with or without food; food intake minimizes stomach upset. Dosage, determined by your doctor based on your child's age, weight, and condition severity, must be strictly adhered to. Report any weight changes to the physician. Unauthorized dosage adjustments risk serious consequences. If vomiting occurs within 30 minutes of administration, reassure your child and repeat the dose unless the next dose is due. Discontinuing treatment abruptly can cause severe adverse reactions; the doctor will gradually reduce the dosage to prevent withdrawal. Pedialyte-C can weaken the immune system, increasing infection susceptibility; regular medical monitoring is crucial. Your doctor may recommend vision and bone density checks, as these can be affected. Potential side effects include weight gain, increased appetite, upper respiratory infections, cough, abnormal hair growth, abdominal fat accumulation, and fluid/electrolyte imbalances. Report any side effects immediately. Inform your child's doctor of all current medications, especially those for infections, and provide a complete medical history, including any cardiac, hematologic, dermatologic, skeletal, endocrine, allergic, ophthalmologic, congenital, pulmonary, hepatic, or renal issues. This information is vital for safe and effective treatment.

Primary Ingredients of Defyuv Oral Suspension

No information provided. Please provide the text you wish me to rephrase.

Uses of Defyuv Oral Suspension

Therapeutic applications encompass oncology, inflammatory disorders, autoimmune diseases, and Duchenne muscular dystrophy (DMD).

Major Benefits of Defyuv Oral Suspension:

Administer Defyuv Oral Suspension precisely as your physician directs, adhering to the prescribed dosage and timeframe. Always consult the product label for complete instructions prior to use. Accurate measurement should be achieved using a designated measuring cup; ingestion is oral. Ensure thorough shaking before each dose. Defyuv Oral Suspension can be consumed with or without food, although consistent timing is recommended. Dietary caution: Avoid consuming Defyuv Oral Suspension concurrently with salads or predominantly vegetable meals.

Common Side effects of Defyuv Oral Suspension:

  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Increased appetite
  • Weight gain
  • Frequent urge to urinate
  • Cushing syndrome
  • Cough
  • Abnormal hair growth
  • Upper respiratory tract infection
  • Obesity

How to use Defyuv Oral Suspension:

Administer Defyuv Oral Suspension precisely as prescribed by your physician, adhering to both dosage and treatment length. Consult the product label for detailed instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Defyuv Oral Suspension can be taken with or without food; however, consistent timing is recommended. Limit consumption of Defyuv Oral Suspension with predominantly raw vegetable meals.

How Defyuv Oral Suspension works:

Defyuv Oral Suspension, a corticosteroid medication, mimics the body's natural anti-inflammatory glucocorticoid hormones. By reducing the production of inflammatory mediators such as prostaglandins, leukotrienes, and interleukins, it diminishes inflammation, allergic responses, and cellular proliferation. Furthermore, it modulates immune system activity, preventing self-harm through the suppression of damaging immune responses.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Defyuv Oral Suspension is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The safety of Defyuv Oral Suspension during pregnancy is uncertain. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the risks and benefits prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Defyuv Oral Suspension to breastfeeding individuals is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Defyuv Oral Suspension.

KidneyKidneySAFE IF PRESCRIBED

Defyuv Oral Suspension is generally safe for individuals with kidney disease and typically doesn't require dosage changes. However, adjustments may be necessary in cases of severe kidney impairment. Always consult your child's physician before administering Defyuv Oral Suspension.

LiverLiverCAUTION

Patients with liver impairment should use Defyuv Oral Suspension judiciously. Dosage modification may be necessary for these patients. Physician consultation is recommended.

What if you forget to take Defyuv Oral Suspension :

Remain calm. Unless otherwise directed by your pediatrician, administer the forgotten dose immediately upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate; instead, continue with the regular dosing instructions.

Facts to Know About Defyuv Oral Suspension

LabelValue
Chemical Type Glucocorticoids, mineralocorticoids, progestins, and their derivatives
Developing Habits No.
Treatment Category Endocrine Signals

FAQs on Defyuv Oral Suspension

Defyuv Oral Suspension is a glucocorticoid, a type of steroid naturally occurring in the body and essential for health. It works by increasing corticosteroid levels, thereby treating inflammatory conditions characterized by redness, tenderness, heat, and swelling.
Do not administer Defyuv Oral Suspension to children with cardiac disease (except active rheumatic carditis), congestive heart failure, hypertension, thromboembolic disorders, or diabetes. Also avoid use if the child has a family history of active tuberculosis, active herpes, osteoporosis, myasthenia gravis, or renal insufficiency.
To ensure safety, children receiving live or live-attenuated vaccines must wait 4–6 weeks before starting Defyuv Oral Suspension. Therefore, all recommended immunizations should be completed before beginning Defyuv Oral Suspension.
Store medication in a cool, dry location, inaccessible to children and pets, to prevent accidental ingestion.
Answer: Defyuv Oral Suspension's extended use may cause mental illness or seizures. Children with existing seizure disorders should not use it.
Defyuv Oral Suspension
114
MRP 132
13% off